Awardee OrganizationUNIVERSITY OF MISSOURI-COLUMBIA
Description
Abstract Text
Project Summary/Abstract
The long-term goal of this research is to reduce the functional impact of cognitive impairment and improve
quality-of-life in women treated for breast cancer with cancer-related cognitive impairment (CRCI). The
prevalence of CRCI following breast cancer is high and can persist chronically after treatment has ended.
Breast cancer survivors often self-report cognitive deficits, primarily in executive functioning (planning, problem
solving, multitasking), memory, and processing speed. These cognitive impairments can have substantial
impacts on everyday life including work, community involvement, driving, and financial management.
Neuroimaging studies suggest this may be due to altered activity in frontoparietal cognitive circuits.
Metacognitive strategy training (MCST), in which participants are taught a general cognitive strategy that can
be applied in known and novel contexts to devise task specific strategies to successfully engage in an activity,
may provide a solution. Our overall research hypothesis is that MCST (1) will be feasible and (2) will improve
behavioral indices of cognitive performance in women with CRCI which are associated with improved neural
activation and functional connectivity in frontoparietal neural circuitry. This project aims to examine the
feasibility of MCST and its impact in women treated for breast cancer on (1) cognitive performance, (2)
frontoparietal resting-state functional connectivity, and (3) task-based BOLD activation and task-state
functional connectivity in cognitive control circuitry. Participants (n=50) will be randomized to a MCST group
(ten, 45-minute sessions over 10 weeks) or an inactive control group. Outcomes will be assessed at pre- and
post-intervention. Feasibility outcomes will be analyzed using descriptive statistics reported with 95%
confidence intervals. Treatment outcomes will be analyzed with an analysis of covariance (ANCOVA) to
compare post-intervention outcomes between groups controlling for pre-test values. Cohen's d effect size with
95% confidence intervals will be reported. Neural outcomes will be examined as mediators of the treatment
group effect on cognitive outcomes with a series of path analyses. Completion of this study is likely to result in
a clinically feasible intervention to improve cognition and activity performance in individuals with CRCI that is
prepared for efficacy testing. The proposed study is consistent with the research priorities of NCI's Division of
Cancer Prevention, the Cancer MoonshotSM program, and PAR-22-216 which are to support research related
to (1) chronic symptom management for improved quality of life and reduced cancer burden and (2) fostering
greater collaboration between disciplines necessary to improve complex behavioral symptoms.
Public Health Relevance Statement
Project Narrative
Breast cancer survivors self-report many cognitive deficits, primarily in executive function (planning,
problem solving, multitasking), after cancer treatment (i.e. cancer-related cognitive impairments (CRCI).
Despite the substantial impact of CRCI, rehabilitation for CRCI is minimal and knowledge to support
intervention is lacking. This proposal evaluates if a novel metacognitive strategy training intervention, that
targets engagement in activity, is feasible and can improve daily life cognitive performance with associated
improvements in activation of neural circuitry underlying executive function.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAftercareAnalysis of CovarianceAttentionAutomobile DrivingBehaviorBehavioralBehavioral SymptomsBrainBreast Cancer PatientBreast Cancer survivorCancer BurdenCancer ModelCancer SurvivorshipChronicClinicalCognitionCognitiveCognitive deficitsCollaborationsComplexConfidence IntervalsControl GroupsDataDisciplineDivision of Cancer PreventionEducational InterventionEducational process of instructingExecutive DysfunctionFosteringFunctional Magnetic Resonance ImagingFutureGoalsHealthImpaired cognitionImpairmentIndividualInterventionKnowledgeLateralLifeLinkLiteratureMalignant Breast NeoplasmMalignant NeoplasmsMeasuresMediatingMediatorMemoryMissionNeuropsychologyNeurosciencesOccupationalOccupational TherapyOccupational activity of managing financesOutcomeParticipantPatient Self-ReportPerformancePreparationPrevalenceProblem SolvingProtocols documentationPublishingQuality of lifeRandomizedRandomized, Controlled TrialsReportingResearchResearch PriorityResearch SupportRestSamplingSeriesSingle-Blind StudyTask PerformancesTestingTherapeuticTrainingTranslational ResearchTraumatic Brain InjuryTreatment outcomeWomanWorkadherence rateattentional controlbehavioral outcomebrain behaviorcancer rehabilitationcancer therapycancer-related cognitive impairmentcognitive controlcognitive performancecommunity involvementcomparison controlefficacy testingevidence based guidelinesexecutive functionimprovedindexinginnovationmultitaskneuralneural circuitneurobiological mechanismneuroimagingnovelpersistent symptompilot testpost interventionprocessing speedprogramsrecruitretention ratestatisticssymptom managementtreatment grouptreatment researchtreatment responsewomen's treatment
No Sub Projects information available for 1R21CA286404-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21CA286404-01A1
Patents
No Patents information available for 1R21CA286404-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21CA286404-01A1
Clinical Studies
No Clinical Studies information available for 1R21CA286404-01A1
News and More
Related News Releases
No news release information available for 1R21CA286404-01A1
History
No Historical information available for 1R21CA286404-01A1
Similar Projects
No Similar Projects information available for 1R21CA286404-01A1